Novo Nordisk is a Danish multinational pharmaceutical company specializing in diabetes care. It was founded in 1923 and has a long history of insulin production. The company also focuses on obesity and rare disease treatments. Novo Nordisk is a global leader in injectable and oral diabetes medications. It invests heavily in R&D for metabolic and endocrine disorders. The firm operates manufacturing facilities in multiple countries. It emphasizes sustainability and access to medicine in developing markets. Novo Nordisk’s products improve the lives of millions worldwide. It has received numerous awards for corporate responsibility. The company is headquartered in Bagsværd, Denmark.